Gut Microbiota and Epigenetics in Colorectal Cancer: Implications for Carcinogenesis and Therapeutic Intervention

References

• El-Salhy M , HatlebakkJG, GiljaOH, BråthenKristoffersen A, HauskenT. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut69(5), 859–867 (2020).
   PubMed Web of Science ®Google Scholar
• Chhikara BS , ParangK. Global Cancer Statistics 2022: the trends projection analysis. Chem. Biol. Lett.10(1), 451, 1–16 (2023).
   Web of Science ®Google Scholar
• Wild CP . Complementing the genome with an ‘exposome’: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev.14(8), 1847–1850 (2005).
   PubMed Web of Science ®Google Scholar
• Hillman ET , LuH, YaoT, NakatsuCH. Microbial ecology along the gastrointestinal tract. Microbes Environ.32(4), 300–313 (2017).
   PubMed Web of Science ®Google Scholar
• Rinninella E , RaoulP, CintoniMet al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms7(1), 14, 1–22 (2019).
   PubMed Web of Science ®Google Scholar
• Carding S , VerbekeK, VipondDT, CorfeBM, OwenLJ. Dysbiosis of the gut microbiota in disease. Microb. Ecol. Health Dis.26, 26191 (2015).
   PubMed Web of Science ®Google Scholar
• Hrncir T . Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options. Microorganisms10(3), 578 (2022).
   Web of Science ®Google Scholar
• Zhao L-Y , MeiJ-X, YuGet al. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Signal Transduct. Target. Ther.8(1), 201 (2023).
   Web of Science ®Google Scholar
• Yamamoto Y , NakanishiY, MurakamiSet al. A metabolomic-based evaluation of the role of commensal microbiota throughout the gastrointestinal tract in mice. Microorganisms6(4), 101 (2018).
   Web of Science ®Google Scholar
• Saputo S , FaustoferriRC, QuiveyRGJ. Vitamin D compounds are bactericidal against Streptococcus mutans and target the bacitracin-associated efflux system. Antimicrob. Agents Chemother.62(1), 10–1128 (2018).
   Web of Science ®Google Scholar
• McFarland LV . Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol.3(5), 563–578 (2008).
   PubMed Web of Science ®Google Scholar
• Gouyer V , DubuquoyL, Robbe-MasselotCet al. Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier. Sci. Rep.5, 9577 (2015).
   Web of Science ®Google Scholar
• Capelluto DGS . Tollip: a multitasking protein in innate immunity and protein trafficking. Microbes Infect.14(2), 140–147 (2012).
   Web of Science ®Google Scholar
• Kelly D , MulderIE. Microbiome and immunological interactions. Nutr. Rev.70(Suppl. 1), S18–S30 (2012).
   Google Scholar
• Zhao Q , ElsonCO. Adaptive immune education by gut microbiota antigens. Immunology154(1), 28–37 (2018).
   Web of Science ®Google Scholar
• Jahani-Sherafat S , AlebouyehM, MoghimS, AhmadiAmoli H, Ghasemian-SafaeiH. Role of gut microbiota in the pathogenesis of colorectal cancer; a review article. Gastroenterol. Hepatol.11(2), 101–109 (2018).
   Google Scholar
• Sobhani I , AmiotA, LeBaleur Yet al. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Ther. Adv. Gastroenterol. 6(3), 215–229 (2013).
   PubMed Web of Science ®Google Scholar
• Lucas C , BarnichN, NguyenHTT. Microbiota, inflammation and colorectal cancer. Int. J. Mol. Sci.18(6), 1310 (2017).
   PubMed Web of Science ®Google Scholar
• Janakiram NB , RaoCV. The role of inflammation in colon cancer. Adv. Exp. Med. Biol.816, 25–52 (2014).
   PubMed Web of Science ®Google Scholar
• Ou J , CarboneroF, ZoetendalEGet al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am. J. Clin. Nutr.98(1), 111–120 (2013).
   PubMed Web of Science ®Google Scholar
• Rubinstein MR , WangX, LiuW, HaoY, CaiG, HanYW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe14(2), 195–206 (2013).
   PubMed Web of Science ®Google Scholar
• Casasanta MA , YooCC, UdayasuryanBet al. Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration. Sci. Signal.13(641), eaba9157 (2020).
   Web of Science ®Google Scholar
• Cougnoux A , DalmassoG, MartinezRet al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut63(12), 1932–1942 (2014).
   PubMed Web of Science ®Google Scholar
• Martin OCB , BergonziniA, D’AmicoFet al. Infection with genotoxin-producing Salmonella enterica synergises with loss of the tumour suppressor APC in promoting genomic instability via the PI3K pathway in colonic epithelial cells. Cell. Microbiol.21(12), e13099 (2019).
   Web of Science ®Google Scholar
• Wang X , HuyckeMM. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology132(2), 551–561 (2007).
   Web of Science ®Google Scholar
• Huycke MM , MooreDR. In vivo production of hydroxyl radical by Enterococcus faecalis colonizing the intestinal tract using aromatic hydroxylation. Free Radic. Biol. Med.33(6), 818–826 (2002).
   PubMed Web of Science ®Google Scholar
• Huycke MM , MooreD, JoyceWet al. Extracellular superoxide production by Enterococcus faecalis requires demethylmenaquinone and is attenuated by functional terminal quinol oxidases. Mol. Microbiol.42(3), 729–740 (2001).
   PubMed Web of Science ®Google Scholar
• Tsoi H , ChuESH, ZhangXet al. Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice. Gastroenterology152(6), 1419–1433.e5 (2017).
   PubMed Web of Science ®Google Scholar
• Mancuso G , MidiriA, BiondoCet al. Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4. Infect. Immun.73(9), 5620–5627 (2005).
   Web of Science ®Google Scholar
• Cheng WT , KantilalHK, DavamaniF. The mechanism of Bacteroides fragilis toxin contributes to colon cancer formation. Malays. J. Med. Sci.27(4), 9–21 (2020).
   Web of Science ®Google Scholar
• Hold GL , GarrettWS. Gut microbiota. Microbiota organization–a key to understanding CRC development. Nat. Rev. Gastroenterol. Hepatol.12(3), 128–129 (2015).
   Web of Science ®Google Scholar
• Niccolai E , RussoE, BaldiSet al. Significant and conflicting correlation of IL-9 with Prevotella and Bacteroides in human colorectal cancer. Front. Immunol.11, 573158 (2020).
   Web of Science ®Google Scholar
• Greer JB , O’KeefeSJ. Microbial induction of immunity, inflammation, and cancer. Front. Physiol.1, 168 (2011).
   PubMed Web of Science ®Google Scholar
• Vargas AJ , ThompsonPA. Diet and nutrient factors in colorectal cancer risk. Nutr. Clin. Pract. Off. Publ. Am. Soc. Parenter. Enter. Nutr.27(5), 613–623 (2012).
   Google Scholar
• Walker AW , InceJ, DuncanSHet al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J.5(2), 220–230 (2011).
   PubMed Web of Science ®Google Scholar
• Louis P , YoungP, HoltropG, FlintHJ. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ. Microbiol.12(2), 304–314 (2010).
   PubMed Web of Science ®Google Scholar
• Chen H-M , YuY-N, WangJ-Let al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am. J. Clin. Nutr.97(5), 1044–1052 (2013).
   PubMed Web of Science ®Google Scholar
• Windey K , DePreter V, VerbekeK. Relevance of protein fermentation to gut health. Mol. Nutr. Food Res.56(1), 184–196 (2012).
   PubMed Web of Science ®Google Scholar
• Holliday R . Mechanisms for the control of gene activity during development. Biol. Rev. Camb. Philos. Soc.65(4), 431–471 (1990).
   PubMed Web of Science ®Google Scholar
• Luger K , MäderAW, RichmondRK, SargentDF, RichmondTJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature389(6648), 251–260 (1997).
   PubMed Web of Science ®Google Scholar
• Castillo J , López-RodasG, FrancoL. Histone post-translational modifications and nucleosome organisation in transcriptional regulation: some open questions. Adv. Exp. Med. Biol.966, 65–92 (2017).
   PubMedGoogle Scholar
• Xie Y-H , ChenY-X, FangJ-Y. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct. Target. Ther.5(1), 22 (2020).
   PubMed Web of Science ®Google Scholar
• Kanwal R , GuptaS. Epigenetic modifications in cancer. Clin. Genet.81(4), 303–311 (2012).
   PubMed Web of Science ®Google Scholar
• Sun D , ChenY, FangJ-Y. Influence of the microbiota on epigenetics in colorectal cancer. Natl Sci. Rev.6(6), 1138–1148 (2018).
   Web of Science ®Google Scholar
• Hu S , LiuL, ChangEB, WangJ-Y, RaufmanJ-P. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells. Mol. Cancer14, 180 (2015).
   PubMed Web of Science ®Google Scholar
• Zullig LL , SmithVA, JacksonGLet al. Colorectal cancer statistics from the Veterans Affairs Central Cancer Registry. Clin. Colorectal Cancer15(4), e199–e204 (2016).
   Web of Science ®Google Scholar
• Kim SW . The role of microRNAs in colorectal cancer. Korean J. Gastroenterol.69(4), 206–211 (2017).
   PubMedGoogle Scholar
• Gao P , TchernyshyovI, ChangT-Cet al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature458(7239), 762–765 (2009).
   PubMed Web of Science ®Google Scholar
• Yuan C , BurnsMB, SubramanianS, BlekhmanR. Interaction between host microRNAs and the gut microbiota in colorectal cancer. mSystems3(3), 10–1128 (2018).
   Web of Science ®Google Scholar
• Liu S , ChangW, JinYet al. The function of histone acetylation in cervical cancer development. Biosci. Rep.39(4), BSR20190527 (2019).
   Google Scholar
• Legube G , TroucheD. Regulating histone acetyltransferases and deacetylases. EMBO Rep.4(10), 944–947 (2003).
   PubMed Web of Science ®Google Scholar
• Yuille S , ReichardtN, PandaS, DunbarH, MulderIE. Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid. PLOS ONE13(7), e0201073 (2018).
   PubMed Web of Science ®Google Scholar
• Takahashi K , SugiY, HosonoA, KaminogawaS. Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis. J. Immunol.183(10), 6522–6529 (2009).
   PubMed Web of Science ®Google Scholar
• Chuang LSH , ItoY. RUNX3 is multifunctional in carcinogenesis of multiple solid tumors. Oncogene29(18), 2605–2615 (2010).
   Web of Science ®Google Scholar
• Ku J-L , KangS-B, ShinY-Ket al. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene23(40), 6736–6742 (2004).
   Web of Science ®Google Scholar
• Jones PA . Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet.13(7), 484–492 (2012).
   PubMed Web of Science ®Google Scholar
• Crider KS , YangTP, BerryRJ, BaileyLB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate’s role. Adv. Nutr.3(1), 21–38 (2012).
   PubMed Web of Science ®Google Scholar
• Wasson GR , McGlynnAP, McNultyHet al. Global DNA and p53 region-specific hypomethylation in human colonic cells is induced by folate depletion and reversed by folate supplementation. J. Nutr.136(11), 2748–2753 (2006).
   PubMed Web of Science ®Google Scholar
• Ansari I , RaddatzG, GutekunstJet al. The microbiota programs DNA methylation to control intestinal homeostasis and inflammation. Nat. Microbiol.5(4), 610–619 (2020).
   PubMed Web of Science ®Google Scholar
• Feinberg AP , OhlssonR, HenikoffS. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet.7(1), 21–33 (2006).
   PubMed Web of Science ®Google Scholar
• Feinberg AP , VogelsteinB. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature301(5895), 89–92 (1983).
   PubMed Web of Science ®Google Scholar
• Kaiko GE , RyuSH, KouesOIet al. The colonic crypt protects stem cells from microbiota-derived metabolites. Cell165(7), 1708–1720 (2016).
   PubMed Web of Science ®Google Scholar
• Gonneaud A , TurgeonN, BoudreauF, PerreaultN, RivardN, AsselinC. Distinct roles for intestinal epithelial cell-specific Hdac1 and Hdac2 in the regulation of murine intestinal homeostasis. J. Cell. Physiol.231(2), 436–448 (2016).
   Web of Science ®Google Scholar
• Tan M , LuoH, LeeSet al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell146(6), 1016–1028 (2011).
   PubMed Web of Science ®Google Scholar
• Wan J , LiuH, ChuJ, ZhangH. Functions and mechanisms of lysine crotonylation. J. Cell. Mol. Med.23(11), 7163–7169 (2019).
   Web of Science ®Google Scholar
• Fellows R , DenizotJ, StellatoCet al. Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases. Nat. Commun.9(1), 105 (2018).
   PubMedGoogle Scholar
• Maslowski KM , VieiraAT, NgAet al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature461(7268), 1282–1286 (2009).
   PubMed Web of Science ®Google Scholar
• Macia L , TanJ, VieiraATet al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun.6, 6734 (2015).
   PubMed Web of Science ®Google Scholar
• Liu L , LiL, MinJet al. Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells. Cell. Immunol.277(1–2), 66–73 (2012).
   PubMed Web of Science ®Google Scholar
• Vinolo MAR , RodriguesHG, FestucciaWTet al. Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice. Am. J. Physiol. Endocrinol. Metab.303(2), E272–E282 (2012).
   PubMed Web of Science ®Google Scholar
• Chang PV , HaoL, OffermannsS, MedzhitovR. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl Acad. Sci. USA111(6), 2247–2252 (2014).
   PubMed Web of Science ®Google Scholar
• Cox MA , JacksonJ, StantonMet al. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J. Gastroenterol.15(44), 5549–5557 (2009).
   PubMed Web of Science ®Google Scholar
• Zeng X , SunkaraLT, JiangWet al. Induction of porcine host defense peptide gene expression by short-chain fatty acids and their analogs. PLOS ONE8(8), e72922 (2013).
   PubMed Web of Science ®Google Scholar
• Millard AL , MertesPM, ItteletD, VillardF, JeannessonP, BernardJ. Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin. Exp. Immunol.130(2), 245–255 (2002).
   PubMed Web of Science ®Google Scholar
• Singh N , ThangarajuM, PrasadPDet al. Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. J. Biol. Chem.285(36), 27601–27608 (2010).
   PubMed Web of Science ®Google Scholar
• Morinobu A , KannoY, O’SheaJJ. Discrete roles for histone acetylation in human T helper 1 cell-specific gene expression. J. Biol. Chem.279(39), 40640–40646 (2004).
   PubMed Web of Science ®Google Scholar
• Kespohl M , VachharajaniN, LuuMet al. The microbial metabolite butyrate induces expression of Th1-associated factors in CD4(+) T cells. Front. Immunol.8, 1036 (2017).
   PubMed Web of Science ®Google Scholar
• Chen L , SunM, WuWet al. Microbiota metabolite butyrate differentially regulates Th1 and Th17 cells’ differentiation and function in induction of colitis. Inflamm. Bowel Dis.25(9), 1450–1461 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang M , ZhouQ, DorfmanRGet al. Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats. BMC Gastroenterol.16(1), 84 (2016).
   Google Scholar
• Sekirov I , RussellSL, AntunesLCM, FinlayBB. Gut microbiota in health and disease. Physiol. Rev.90(3), 859–904 (2010).
   PubMed Web of Science ®Google Scholar
• Zhou L , ZhangM, WangYet al. Faecalibacterium prausnitzii produces butyrate to maintain Th17/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1. Inflamm. Bowel Dis.24(9), 1926–1940 (2018).
   PubMed Web of Science ®Google Scholar
• Wu S-E , Hashimoto-HillS, WooVet al. Microbiota-derived metabolite promotes HDAC3 activity in the gut. Nature586(7827), 108–112 (2020).
   PubMed Web of Science ®Google Scholar
• Luu M , PautzS, KohlVet al. The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nat. Commun.10(1), 760 (2019).
   PubMedGoogle Scholar
• Furusawa Y , ObataY, FukudaSet al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature504(7480), 446–450 (2013).
   PubMed Web of Science ®Google Scholar
• Beier UH , WangL, HanR, AkimovaT, LiuY, HancockWW. Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. Sci. Signal.5(229), ra45 (2012).
   PubMed Web of Science ®Google Scholar
• Wang L , LiuY, HanRet al. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3. J. Clin. Invest.125(3), 1111–1123 (2015).
   PubMed Web of Science ®Google Scholar
• Kim M , QieY, ParkJ, KimCH. Gut microbial metabolites fuel host antibody responses. Cell Host Microbe20(2), 202–214 (2016).
   PubMed Web of Science ®Google Scholar
• Sanchez HN , MoroneyJB, GanHet al. B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids. Nat. Commun.11(1), 60 (2020).
   PubMed Web of Science ®Google Scholar
• Chen Y-C , ChuangC-H, MiaoZ-Fet al. Gut microbiota composition in chemotherapy and targeted therapy of patients with metastatic colorectal cancer. Front. Oncol.12, 955313 (2022).
   Web of Science ®Google Scholar
• Sanders ME , MerensteinDJ, ReidG, GibsonGR, RastallRA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat. Rev. Gastroenterol. Hepatol.16(10), 605–616 (2019).
   PubMed Web of Science ®Google Scholar
• Ting NL-N , LauHC-H, YuJ. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes. Gut71(7), 1412–1425 (2022).
   Web of Science ®Google Scholar
• Holscher HD . Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes8(2), 172–184 (2017).
   PubMed Web of Science ®Google Scholar
• Guarino MPL , AltomareA, EmerenzianiSet al. Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults. Nutrients12(4), 1037 (2020).
   Web of Science ®Google Scholar
• Hill C , GuarnerF, ReidGet al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol.11(8), 506–514 (2014).
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan V , SpencerCN, NeziLet al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science359(6371), 97–103 (2018).
   PubMed Web of Science ®Google Scholar
• Zaharuddin L , MokhtarNM, MuhammadNawawi KN, RajaAli RA. A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer. BMC Gastroenterol.19(1), 131 (2019).
   PubMedGoogle Scholar
• Ghanavati R , AsadollahiP, ShapourabadiMB, RazaviS, TalebiM, RohaniM. Inhibitory effects of lactobacilli cocktail on HT-29 colon carcinoma cells growth and modulation of the Notch and Wnt/β-catenin signaling pathways. Microb. Pathog.139, 103829 (2020).
   Web of Science ®Google Scholar
• Zhang Q , ZhaoQ, LiTet al. Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8(+) T cell immunity. Cell Metab.35(6), 943–960 (2023).
   Web of Science ®Google Scholar
• Lee HA , KimH, LeeK-W, ParkK-Y. Dead nano-sized Lactobacillus plantarum inhibits azoxymethane/dextran sulfate sodium-induced colon cancer in Balb/c mice. J. Med. Food18(12), 1400–1405 (2015).
   PubMed Web of Science ®Google Scholar
• Sivan A , CorralesL, HubertNet al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science350(6264), 1084–1089 (2015).
   PubMed Web of Science ®Google Scholar
• Vétizou M , PittJM, DaillèreRet al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science350(6264), 1079–1084 (2015).
   PubMed Web of Science ®Google Scholar
• Tukenmez U , AktasB, AslimB, YavuzS. The relationship between the structural characteristics of lactobacilli-EPS and its ability to induce apoptosis in colon cancer cells in vitro. Sci. Rep.9(1), 8268 (2019).
   PubMedGoogle Scholar
• Halkjær SI , LoB, ColdFet al. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. World J. Gastroenterol.29(20), 3185–3202 (2023).
   Web of Science ®Google Scholar
• Blanchaert C , StrubbeB, PeetersH. Fecal microbiota transplantation in ulcerative colitis. Acta Gastroenterol. Belg.82(4), 519–528 (2019).
   Web of Science ®Google Scholar
• Routy B , LeChatelier E, DerosaLet al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science359(6371), 91–97 (2018).
   PubMed Web of Science ®Google Scholar
• Viaud S , SaccheriF, MignotGet al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science342(6161), 971–976 (2013).
   PubMed Web of Science ®Google Scholar
• Xu H , CaoC, RenYet al. Antitumor effects of fecal microbiota transplantation: implications for microbiome modulation in cancer treatment. Front. Immunol.13, 949490 (2022).
   Web of Science ®Google Scholar